Bottom line
IDNA vs ETHSX: the short answer
IDNA (iShares Genomics Immunology and Healthcare ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.
IDNA is cheaper at 0.47% vs 1.18% — a difference of $71 a year per $10,000 invested.
Over five years, ETHSX returned +5.3% a year vs −4.8% for IDNA.
ETHSX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
IDNA vs ETHSX side by side
| IDNA | ETHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | Morgan Stanley |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.47% | 1.18% |
| Annual cost per $10k | $47 | $118 |
| 10-yr cost on $10k (prospectus) | $591 | $1,911 |
| Max front load | None | 5.25% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | −1.0% | −1.9% |
| 5-yr return (annualized) | −4.8% | +5.3% |
| 10-yr return (annualized) | — | +6.4% |
| Best quarter | +41.9% | +14.2% |
| Worst quarter | −21.5% | −12.1% |
| Net assets (fund) | $190.9M | $757.9M |
| Number of holdings | 61 | 42 |
| Portfolio turnover | 49% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IDNA | ETHSX | Difference |
|---|---|---|---|
| 2024 | −1.0% | +3.5% | −4.5% |
| 2023 | −7.8% | +5.7% | −13.4% |
| 2022 | −42.1% | −9.4% | −32.7% |
| 2021 | −4.0% | +22.1% | −26.1% |
| 2020 | +54.5% | +13.0% | +41.5% |
Source: Fund prospectus bar charts
Holdings overlap
4 of IDNA's top 25 holdings also appear in ETHSX's top 25.
| Holding | IDNA | ETHSX |
|---|---|---|
| Merck & Co., Inc. | 3.91% | 5.08% |
| Vertex Pharmaceuticals Incorporated | 3.87% | 3.38% |
| Roche Holding AG | 3.85% | 5.44% |
| Sanofi Sa | 3.46% | 2.95% |
Source: SEC Form N-PORT
IDNA top 10
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
- Bayer Aktiengesellschaft — 4.81%
- Twist Bioscience Corp — 4.79%
- Revolution Medicines, Inc. — 4.55%
- Regeneron Pharmaceuticals, Inc. — 4.35%
- Genmab A/s — 4.23%
- Incyte Corporation — 4.23%
- Moderna, Inc. — 4.19%
- Takeda Pharmaceutical Company Limited — 4.05%
- Merck & Co., Inc. — 3.91%
ETHSX top 10
- Eli Lilly & Co — 12.47%
- AbbVie Inc — 6.46%
- Johnson & Johnson — 6.45%
- AstraZeneca PLC — 6.24%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Merck & Co Inc — 5.08%
- Bristol-Myers Squibb Co — 4.25%
- Vertex Pharmaceuticals Inc — 3.38%
- Gilead Sciences Inc — 3.34%
FAQ
What is the difference between IDNA and ETHSX?
Which is cheaper, IDNA or ETHSX?
Should I own both IDNA and ETHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.